Related Experiment Video
Updated: Aug 8, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
[Markers of hepatitis C and its various genotypes in patients from Novosibirsk]
Insights
Hepatitis C virus (HCV) infection is prevalent in Novosibirsk, with high rates of antibodies and RNA detected. Genetic analysis revealed subtype 1b as dominant, alongside other genotypes and novel mutations in Siberian HCV isolates.
Area of Science:
- Virology
- Infectious Diseases
- Genetics
Context:
- Hepatitis C virus (HCV) poses a significant global health challenge.
- Understanding HCV prevalence and genetic diversity is crucial for effective treatment and prevention strategies.
- This study focuses on HCV markers in patients from a specific region in Siberia.
Purpose:
- To determine the prevalence of hepatitis C virus (HCV) markers in patients at a Novosibirsk hospital.
- To analyze the genetic diversity of HCV isolates from Siberian patients by sequencing the 5'-UTR region.
- To identify known and novel genetic variations within the sequenced HCV isolates.
Summary:
- The study screened 153 patients, finding anti-HCV in 88.2% and viral RNA in 69.3%.
- Sequencing of the 5'-UTR region in 93 Siberian HCV isolates identified subtype 1b as the most common (63.4%), followed by genotype 2 (7.5%) and genotype 3 (18.3%).
- A significant proportion of isolates (10.8%) exhibited unique nucleotide substitutions, insertions, or deletions in the 5'-UTR, indicating novel genetic variations.
Impact:
- Provides essential data on HCV prevalence and genetic distribution in the Siberian population.
- Highlights the predominance of HCV subtype 1b and the presence of previously undescribed viral variants.
- Informs public health initiatives and antiviral drug development by detailing regional HCV genetic landscape.
Abstract:
Study of the prevalence of hepatitis C virus (HCV) markers in 153 patients of Municipal Infectious Diseases Clinical Hospital No. 1 in Novosibirsk revealed anti-HCV in 88.2% patients and viral RNA in 69.3% samples. For 93 Siberian HCV isolates 5'-UTR regions were amplified and sequenced. Comparison of these nucleotide sequences with databank showed that 63.4% HCV isolates belonged to subtype 1b, 7.5% to genotype 2, and 18.3% to genotype 3. In the rest HCV isolates the 5'-UTR sequences contained heretofore undescribed nucleotide substitutions, insertions, or deletions.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction

